Supplier News

LabCorp announced it will purchase contract research company Covance Inc. for approximately $6.1 billion in cash and stock.

Sigma-Aldrich's custom manufacturing services business unit, SAFC, has launched a new protein quality supplement for biological drug production, including biosimilars.

The WuXi AppTec bulk cell culture production facility, designed by Sartorius Stedim Biotech (SSB), received an honorable mention in the 2014 Facility of the Year Awards at the annual meeting of International Society for Pharmaceutical Engineering (ISPE) in Las Vegas last week.

BioReliance has introduced select in vitro ADME (absorption, distribution, metabolism and excretion) and toxicology testing services its service offering. The company?s range of predictive assays use a novel suite of genetically modified cell lines created with CompoZr zinc finger nuclease (ZFN), a Sigma-Aldrich proprietary technology.

CSL Behring announced that it plans to invest $450 million to expand its Melbourne, Australia and Kankakee, Illinois facilities, which will increase production of albumin and plasma intermediates.

Celebrating the best of pharma and recognizing companies that turn inspiration into innovation.

Regulations, product protection, and cost management are top concerns of supply chain decision makers.

PCI's acquisition of Biotech Services International expands the packaging services provider's presence in Europe.

Texas A&M dedicates national pandemic influenza vaccine manufacturing facility.

Catalent's addition of an automated prefilled syringe clinical packaging line at its Philadelphia facility will support its work with Eli Lilly.

PSC Investments announces the acquisition of a high potency, sterile fill/finish pharmaceutical manufacturing facility.

Redbiotec and GE Healthcare Life Sciences develop a novel manufacturing process for virus-like particles.

SGS to add testing laboratories for biotechnology, extractables and leachables, and elemental impurities to Shanghai facility.

CPI invests &34 million to develop a Biologics Factory of the Future due to open in 2017.

ASTM International develops Committee E62, a new technical committee focused on industrial biotechnology.

Covance reports two senior-level appointments to it clinical development services scientific leadership team.

Aesica adds roller compaction unit for dry granulation production.

BioOutsource will expand its US presence, opening a new laboratory facility in Massachusetts to support the company's biosimilar and biosafety service offerings.

Covance MarketPlace is designed to enable partnerships between the company's emerging biotechnology and established pharmaceutical clients.

Aesica Pharmaceuticals S.r.I. collaborates with QAD to meet China's Food and Drug Administration's shortened serialization deadline.

Rentschler plans to build two stainless-steel bioreactors to target market supply.

Arecor and the Center for Process Innovation (CPI) Biologics are working on a project to enhance the compatibility of biologics with their containers.

Catalent and AAPS announce the five winners of its annual academic competition.

Cellectis enters an agreement with CELLforCURE for cGMP clinical manufacturing of allogeneic T-cells.

AMRI adds commercial-scale sterile injectable manufacturing capabilities with acquisition of Oso Biopharmaceuticals.

PacificGMP doubles its GMP production capacity with the addition of a second System 1000 Bioreactor platform.

GE Healthcare introduces the Cytiva Plus Cardiomyocytes, a high fidelity human heart cell model.

Rockland Immunochemicals develops new laboratories in Limerick, PA.